Is GAN or CL a better dividend investment in 2026?

GAN currently yields 101.52% with a 5% 5-year dividend growth rate. CL yields 2.43% with 5% growth. The better choice depends on your goal: GAN offers higher current income.

What is the dividend yield difference between GAN and CL?

GAN has a forward dividend yield of 101.52% ($2.00/share annually). CL yields 2.43% ($2.08/share annually). The yield gap is 99.09 percentage points.

Home › Compare › GAN vs CL

GAN vs CL: Dividend Comparison 2026

GAN yields 101.52% · CL yields 2.43%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 GAN wins by $4.10M in total portfolio value

INVESTMENT

TIME HORIZON10 years

GAN

● Live price

101.52%

Share price

$1.97

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.15M

Annual income

$1,411,051.39

Full GAN calculator →

● Live price

2.43%

Share price

$85.73

Annual div

$2.08

5Y div CAGR

28.6%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$40.8K

Annual income

$5,401.96

Full CL calculator →

Portfolio growth — GAN vs CL

📍 GAN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	GAN	CL
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, GAN + CL cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

GAN pays

CL pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GAN

Annual income on $10K today (after 15% tax)

$8,629.44/yr

After 10yr DRIP, annual income (after tax)

$1,199,393.68/yr

Annual income on $10K today (after 15% tax)

$206.23/yr

After 10yr DRIP, annual income (after tax)

$4,591.67/yr

At 15% tax rate, GAN beats the other by $1,194,802.02/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GAN + CL for your $10,000?

GAN: 50%CL: 50%

100% CL50/50100% GAN

Portfolio after 10yr

$2.09M

Annual income

$708,226.68/yr

Blended yield

33.84%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

GAN

Analyst Ratings

Buy

Hold

Consensus: Hold

Altman Z

-3.6

Piotroski

3/9

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$92.45

+7.8% upside vs current

Range: $85.00 — $100.00

Altman Z

4.5

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GAN buys

CL buys

No recent congressional trades found for GAN or CL in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricGANCL

Forward yield	101.52% ✓	2.43%
Annual dividend / share	$2.00	$2.08 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28.6% ✓
Portfolio after 10y	$4.15M	$40.8K ✓
Annual income after 10y	$1,411,051.39 ✓	$5,401.96
Total dividends collected	$3.71M	$18.0K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Staples
Analyst consensus	Hold	Hold

Year-by-year: GAN vs CL ($10,000, DRIP)

Year	GAN Portfolio	GAN Income/yr	CL Portfolio	CL Income/yr	Gap
1← crossover	$20,852	$10,152.28	$11,012	$312.01	+$9.8K → GAN
2	$42,097	$19,784.89	$12,196	$412.95	+$29.9K → GAN
3	$82,373	$37,328.94	$13,599	$549.66	+$68.8K → GAN
4	$156,403	$68,264.51	$15,288	$736.64	+$141.1K → GAN
5	$288,488	$121,136.25	$17,353	$995.28	+$271.1K → GAN
6	$517,502	$208,819.97	$19,926	$1,357.80	+$497.6K → GAN
7	$903,811	$350,084.51	$23,194	$1,873.82	+$880.6K → GAN
8	$1,538,498	$571,419.57	$27,439	$2,621.52	+$1.51M → GAN
9	$2,555,248	$909,055.50	$33,088	$3,727.38	+$2.52M → GAN
10	$4,145,167	$1,411,051.39	$40,806	$5,401.96	+$4.10M → GAN

GAN vs CL: Complete Analysis 2026

GAN — Stock

GAN Limited operates as a business-to-business (B2B) supplier of enterprise software-as-a-service solutions to online casino gaming and sports betting applications in the United States, Europe, Latin America, and internationally. The company operates in two segments, B2B and Business-to-Consumer (B2C). It offers and licenses GameSTACK, an internet gaming platform that provides turnkey technology solution for regulated real-money internet gambling, online sports betting, and virtual simulated gaming. The company also offers online sports betting, online casino game, and peer-to-peer poker services through its coolbet.com website, as well as a range of development, marketing, and customer support services designed to deploy and provide ongoing operational support for its software systems. It serves regional operators and individual tribal casino operators. The company was incorporated in 1999 and is headquartered in Irvine, California.

Full GAN Calculator →

CL — Consumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →

📬

Get this GAN vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GAN vs SCHD GAN vs JEPI GAN vs O GAN vs KO GAN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.